Programmed cell death protein 1 (PD-1) inhibitors may exacerbate autoimmunity by impairing Treg-mediated suppression, thereby facilitating the activation of autoreactive B cells and promoting the production of red blood cell-specific autoantibodies, including immunoglobulin G (IgG). This evidence concerns the gene PDCD1 and Autoimmunity.